Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-oesophageal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Testing effectiveness (Phase 2)UnknownNCT05184946
What this trial is testing

Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
The Second Affiliated Hospital of Shandong First Medical University 72
Testing effectiveness (Phase 2)Ended earlyNCT00098527
What this trial is testing

FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the StomachRecurrent Esophageal Cancer+1 more
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT01295086
What this trial is testing

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Who this might be right for
Adenocarcinoma
Odense University Hospital 27
Early research (Phase 1)Looking for participantsNCT07284186
What this trial is testing

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Esophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastric Squamous Cell Carcinoma+7 more
Plexium, Inc. 155
Testing effectiveness (Phase 2)Looking for participantsNCT06808971
What this trial is testing

Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 61
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Study completedNCT02251951
What this trial is testing

Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer

Who this might be right for
Stomach and Gastro-Esophageal Junction (GEJ) Cancer
Hellenic Oncology Research Group 39
Early research (Phase 1)Study completedNCT01770353
What this trial is testing

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Who this might be right for
Solid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more
Ipsen 45
Not applicableUnknownNCT04774367
What this trial is testing

Evaluation of the Reliability of the Determination of MisMatch Repair Deficiency Status by Endoscopic Biopsies in Oesophagus and Gastric Adenocarcinoma.

Who this might be right for
Gastro-oesophageal Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Study completedNCT01212822
What this trial is testing

Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+17 more
Fox Chase Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT04014075
What this trial is testing

DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)

Who this might be right for
Adenocarcinoma Gastric Stage IV With MetastasesAdenocarcinoma - GEJ
Daiichi Sankyo 79
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Temporarily pausedNCT05135845
What this trial is testing

Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma

Who this might be right for
Oesophageal AdenocarcinomaGastric Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 90
Early research (Phase 1)Study completedNCT02013154
What this trial is testing

DKN-01 in Combination With Paclitaxel or Pembrolizumab

Who this might be right for
Esophageal NeoplasmsAdenocarcinoma of the Gastroesophageal JunctionGastroesophageal Cancer+2 more
Leap Therapeutics, Inc. 151
Testing effectiveness (Phase 2)UnknownNCT03966118
What this trial is testing

Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaAdenocarcinoma of the Stomach
P. C. Thuss-Patience 59
Not applicableUnknownNCT04269083
What this trial is testing

A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction

Who this might be right for
Esophageal Cancer
Azienda Ospedaliera Universitaria Integrata Verona 128
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Next Page